Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab Academic Article uri icon

Overview

publication date

  • 2015

Identity

PubMed ID

  • 24730538